Research Article
Antibiotic Therapies in Maxillofacial Surgery in the Context of Prophylaxis
Table 5
Susceptibility of Gram-positive and Gram-negative bacteria to antibiotics in 2008–2010 and 2011-2012.
| | Antibiotic | Gram-positive | Gram-negative | | 2008–2010 | 2011-2012 | 5 years | 2008–2010 | 2011-2012 | 5 years |
| | Ampicillin | 124 (89.9%) | 93 (69.9%) | 223 (82%) | 27 (36.5%) | 17 (38.6%) | 44 (37.3%) | | Amoxicillin clavulanate | N/A | N/A | N/A | 42 (64.6%) | 28 (60.9%) | 70 (63%) | | Ciprofloxacin | 75 (87.2%) | 20 (80%) | 95 (85.6%) | 60 (87%) | 25 (89.3%) | 85 (87.6%) | | Sulfamethoxazole/ trimethoprim | 139 (91.4%) | 139 (82.4%) | 275 (86.7%) | 40 (75.5%) | 54 (77.14%) | 94 (74%) | | Gentamicin | 105 (94.6%) | 86 (84.3%) | 191 (89.7%) | 51 (94.4%) | 56 (87.5%) | 107 (90.7%) | | Vancomycin | 248 (100%) | 260 (98.8%) | 508 (99.4%) | N/A | N/A | N/A | | Imipenem | 22 (100%) | 30 (83.3%) | 52 (89.6%) | 69 (92%) | 5 (90%) | 123 (91.1%) | | Clindamycin | 171 (66.8%) | 148 (61.4%) | 319 (64.2%) | N/A | N/A | N/A | | Penicillin | 135 (53.4%) | 119 (50.4%) | 254 (51.9%) | N/A | N/A | N/A |
|
|
N/A: not applicable.
|
